高橋 雅英

Medicine & Life Sciences

1. Glial Cell Line-Derived Neurotrophic Factor 100%
2. Proteins 61%
3. Proto-Oncogenes 60%
4. Mutation 55%
5. Tyrosine 55%
6. Protein-Tyrosine Kinases 50%
7. Multiple Endocrine Neoplasia Type 2a 49%
8. Neoplasms 49%
9. Multiple Endocrine Neoplasia 48%
10. Transgenic Mice 41%
11. Phosphorylation 40%
12. Hirschsprung Disease 39%
13. Cancer-Associated Fibroblasts 38%
14. Genes 35%
15. Proto-Oncogene Proteins c-ret 34%
16. Fingers 31%
17. Phosphotransferases 30%
18. Microfilament Proteins 27%
19. Cell Movement 26%
20. Multiple Endocrine Neoplasia Type 2b 25%
21. Cell Line 24%
22. Glial Cell Line-Derived Neurotrophic Factor Receptors 24%
23. Oncogenes 23%
24. Oncogene Proteins 21%
25. Breast Neoplasms 21%
26. Neuroblastoma 19%
27. Glycosylphosphatidylinositols 19%
28. Neurturin 19%
29. Medullary Thyroid cancer 19%
30. Phosphatidylinositol 3-Kinase 19%
31. Neurons 17%
32. Metallothionein 17%
33. Familial medullary thyroid carcinoma 17%
34. Phenotype 17%
35. Cysteine 17%
36. Mouse mammary tumor virus 17%
37. Enteric Nervous System 17%
38. Carcinogenesis 15%
39. Inbred BUF Rats 15%
40. Lung Neoplasms 15%
41. Receptor Protein-Tyrosine Kinases 14%
42. Microtubules 14%
43. Squamous Cell Carcinoma 14%
44. Germ-Line Mutation 13%
45. Exons 13%
46. Dimerization 13%
47. Actin Cytoskeleton 13%
48. Melanoma 13%
49. Antibodies 13%
50. Actins 13%